|
|
|||||||
Red Cell Disorders |
1 Inserm U-522, IFR 140, University Hospital Pontchaillou, Rennes, France
2 Ospedale San Eugenio, Day Hospital Talassemie, Rome, Italy
3 Ospedale Oncologico, Divisione di Ematologia, Cagliari, Italy
4 Ospedale Regionale per le Microcitemie, Centro Talassemici Adulti, Dipartimento Scienze Mediche, Università degli Studi di Cagliari, Italy
Correspondence: Pierre Brissot, Service des Maladies du Foie, Hôpital Pontchaillou 35033 Rennes Cedex, France. E-mail: pierre.brissot{at}univ-rennes1.fr
Thalassemia associates anemia and iron overload, two opposite stimuli regulating hepcidin gene expression. We characterized hepatic hepcidin expression in 10 thalassemia major and 13 thalassemia intermedia patients. Hepcidin mRNA levels were decreased in the thalassemia intermedia group which presented both lower hemoglobin and higher plasma soluble transferrin receptor levels. There was no relationship between hepcidin mRNA levels and those of genes controlling iron metabolism, including HFE, hemojuvelin, transferrin receptor-2 and ferroportin. These results underline the role of erythropoietic activity on hepcidin decrease in thalassemic patients and suggest that mRNA modulations of other studied genes do not have a significant impact.
Key words: anemia, β-thalassemia, hepcidin, gene expression, iron overload.
| HOME | HELP | FEEDBACK | TABLE OF CONTENTS | ARCHIVE | SUBSCRIPTIONS |